Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × In Situ Hybridization, Fluorescence × Clear all

NCT00499655 2017-03-29

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Phase 2 Completed

107 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung